Ginkgo Bioworks Holdings (DNA) Non-Current Deffered Revenue (2020 - 2025)
Historic Non-Current Deffered Revenue for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Q3 2025 value amounting to $74.1 million.
- Ginkgo Bioworks Holdings' Non-Current Deffered Revenue fell 2962.08% to $74.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $74.1 million, marking a year-over-year decrease of 2962.08%. This contributed to the annual value of $98.8 million for FY2024, which is 3750.36% down from last year.
- Latest data reveals that Ginkgo Bioworks Holdings reported Non-Current Deffered Revenue of $74.1 million as of Q3 2025, which was down 2962.08% from $74.6 million recorded in Q2 2025.
- Ginkgo Bioworks Holdings' 5-year Non-Current Deffered Revenue high stood at $179.9 million for Q2 2023, and its period low was $60.4 million during Q1 2021.
- Over the past 5 years, Ginkgo Bioworks Holdings' median Non-Current Deffered Revenue value was $156.0 million (recorded in 2021), while the average stood at $133.0 million.
- Its Non-Current Deffered Revenue has fluctuated over the past 5 years, first surged by 18186.5% in 2022, then crashed by 5159.91% in 2025.
- Over the past 5 years, Ginkgo Bioworks Holdings' Non-Current Deffered Revenue (Quarter) stood at $156.0 million in 2021, then grew by 12.04% to $174.8 million in 2022, then dropped by 9.56% to $158.1 million in 2023, then crashed by 37.5% to $98.8 million in 2024, then fell by 25.02% to $74.1 million in 2025.
- Its last three reported values are $74.1 million in Q3 2025, $74.6 million for Q2 2025, and $80.4 million during Q1 2025.